Parallel Advisors’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8K | Buy |
618
+380
| +160% | +$3.56K | ﹤0.01% | 2658 |
|
|
2025
Q1 | $1.69K | Sell |
238
-85
| -26% | -$604 | ﹤0.01% | 3008 |
|
|
2024
Q4 | $3.77K | Buy |
323
+317
| +5,283% | +$3.7K | ﹤0.01% | 2718 |
|
|
2024
Q3 | $123 | Sell |
6
-33
| -85% | -$677 | ﹤0.01% | 3313 |
|
|
2024
Q2 | $873 | Sell |
39
-36
| -48% | -$806 | ﹤0.01% | 2979 |
|
|
2024
Q1 | $2.06K | Sell |
75
-192
| -72% | -$5.28K | ﹤0.01% | 2819 |
|
|
2023
Q4 | $8.14K | Sell |
267
-22
| -8% | -$671 | ﹤0.01% | 2364 |
|
|
2023
Q3 | $9.14K | Buy |
289
+50
| +21% | +$1.58K | ﹤0.01% | 2246 |
|
|
2023
Q2 | $9.75K | Sell |
239
-49
| -17% | -$2K | ﹤0.01% | 2178 |
|
|
2023
Q1 | $10.7K | Buy |
288
+114
| +66% | +$4.25K | ﹤0.01% | 2097 |
|
|
2022
Q4 | $6.07K | Sell |
174
-4
| -2% | -$140 | ﹤0.01% | 2246 |
|
|
2022
Q3 | $10K | Buy |
178
+1
| +0.6% | +$56 | ﹤0.01% | 1980 |
|
|
2022
Q2 | $9K | Sell |
177
-23
| -12% | -$1.17K | ﹤0.01% | 2026 |
|
|
2022
Q1 | $14K | Buy |
200
+1
| +0.5% | +$70 | ﹤0.01% | 1856 |
|
|
2021
Q4 | $24K | Sell |
199
-66
| -25% | -$7.96K | ﹤0.01% | 1687 |
|
|
2021
Q3 | $36K | Buy |
265
+141
| +114% | +$19.2K | ﹤0.01% | 1419 |
|
|
2021
Q2 | $20K | Sell |
124
-26
| -17% | -$4.19K | ﹤0.01% | 1666 |
|
|
2021
Q1 | $12K | Buy |
150
+115
| +329% | +$9.2K | ﹤0.01% | 1829 |
|
|
2020
Q4 | $2K | Buy |
+35
| New | +$2K | ﹤0.01% | 2312 |
|
|
2017
Q4 | – | Sell |
-1,000
| Closed | -$20K | – | 2120 |
|
|
2017
Q3 | $20K | Buy |
+1,000
| New | +$20K | ﹤0.01% | 1007 |
|